Shifting the treatment paradigm can lead to less pain and inflammation.
Leela V. Raju, MD
Advertisement
Articles by Leela V. Raju, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Q&A: What’s in the glaucoma treatment pipeline?
2
FDA grants single-patient expanded access for urcosimod in neuropathic corneal pain
3
SpyGlass Pharma randomizes first patients in 2 phase 3 clinical trials of the BIM-IOL System
4
Sneak peek: What’s ahead at the second International Glaucoma Symposium in Mainz, Germany
5